Challenging management of hepatitis B infection in ankylosing spondylitis patients in an endemic area during immunosuppressive therapy
Rev. Soc. Bras. Med. Trop
;
52: e20180386, 2019. graf
Artículo
en Inglés
| LILACS
| ID: biblio-990436
ABSTRACT
Abstract Hepatitis B infection is a global health issue. When considering patients with rheumatic diseases, this is no different. By using immunosuppressant drugs, such as DMARDs and biologics, viral reactivation is possible, leading to serious consequences on the patient. We report 3 cases of association between ankylosing spondylitis and hepatitis B with the use of immunosuppressant drugs. Case 1 was a patient with previous HBV infection using DMARD. Cases 2 and 3 were patients chronically infected by HBV during immunosuppressant therapy. The management of HBV infection during immunosuppressant therapy is challenging and needs multidisciplinary support.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Espondilitis Anquilosante
/
Activación Viral
/
Antirreumáticos
/
Hepatitis B
/
Inmunosupresores
Límite:
Femenino
/
Humanos
/
Embarazo
Idioma:
Inglés
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
Medicina Tropical
Año:
2019
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Hospital Universitário Getúlio Vargas/BR
/
Universidade Federal do Amazonas/BR
/
Universidade Nilton Lins/BR
Similares
MEDLINE
...
LILACS
LIS